Experimental cancer drug shows promise for Parkinson's
A drug originally developed for prostate cancer may have exciting potential for treating Parkinson's, according to research published today in Cell Stem Cell.
People who smoke may be less likely to develop Parkinson's
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Stopping the build-up of toxic proteins in Parkinson's
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
Research points to the appendix being the source of Parkinson's
Results published today in the scientific journal Science Translational Medicine highlights a link between the removal of the appendix and a reduced risk of developing Parkinson's.
10,000 people without Parkinson's needed for online study
The UK-wide Predict PD study, funded by Parkinson's UK, is seeking 10,000 people aged 60-80 without Parkinson's to find clues to the very earliest stages of the condition.
Promising early results for potential new treatment for Parkinson's
The pharmaceutical company Biogen has presented promising initial results from trials testing a potential new treatment for Parkinson's which targets the alpha-synuclein protein.
People with ADHD may be at increased risk of Parkinson's
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Positive results for a breath test for Parkinson's
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
New cell transplant trial to start in Japan
Researchers in Japan have announced clinical trials of a stem cell-based treatment for Parkinson's will start this month.